Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,
Tag: Borrelia burgdorferi
Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease vaccine candidate,
Lyme disease has been strongly concentrated in the North American Midwest and Northeastern regions, where ticks and contact with ticks are common. According to